CAMBRIDGE NUTRITIONAL SCIENCES PLC — Director's Dealing 2020

Jan 24, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7933A

Omega Diagnostics Group PLC

24 January 2020

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Grant of Options under Company EMI Plan

Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing, announces that certain Directors and PDMRs were granted options on 23 January 2020 (the "Grant Date") to subscribe for an aggregate of 3,150,000 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") at an exercise price of 15.4 pence per Ordinary Share (the "Options"). The Options are being granted under the Company's 2020 EMI Plan. The Options shall have a two-year vesting period, after which the Option may then be exercised in whole or in part in accordance with the Rules of the Plan.

A full break down of Directors and PDMRs being granted the Options is provided below:

Name	Director or PDMR	Current Options	Proposed Option award	Total Options after award
Colin King	Chief Executive Officer	1,200,000	950,000	2,150,000
Kieron Harbinson	Group Finance Director	940,000	750,000	1,690,000
Jag Grewal	Group Commercial Director	910,000	500,000	1,410,000
Edward Valente	PDMR	300,000	100,000	400,000
Mike Gordon	PDMR	290,000	100,000	390,000
Jamie Yexley	PDMR	225,000	100,000	325,000
Patrick Breen	PDMR	45,000	150,000	195,000
Angela Robertson	PDMR	25,000	100,000	125,000
John Bannister	PDMR	230,000	100,000	330,000
Derek Brady	PDMR	0	150,000	150,000
Jill Hepburn	PDMR	0	150,000	150,000
Total		4,165,000	3,150,000	7,315,000

The Options issued to Colin King, Kieron Harbinson and Jag Grewal contain an additional performance condition which states the Option shall not be capable of being exercised unless and until the middle-market quotation of a Share is equal or greater than 30p at any time on or after the second anniversary of the Grant Date, after which the Option may then be exercised in whole or in part in accordance with the Rules of the Plan as if no further Performance Condition applied.

Following the Option award, there are a total of 13,645,406 unexercised options over Ordinary Shares in the Company, representing 9.07 per cent. of the issued share capital.

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

Contacts: 

Omega Diagnostics Group PLC	Tel: 01259 763 030
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: 020 7220 0500
Geoff Nash/Hannah Boros (Corporate Finance)
Camille Gochez (Corporate Broking)
Walbrook PR Limited	Tel: 020 7933 8780 or [email protected]
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Kieron Harbinson

2

Reason for the notification

a)

Position / status

Group Finance Director

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	750,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Colin King

2

Reason for the notification

a)

Position / status

CEO

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	950,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Jag Grewal

2

Reason for the notification

a)

Position / status

Group Commercial Director

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	500,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Edward Valente

2

Reason for the notification

a)

Position / status

PDMR

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	100,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Mike Gordon

2

Reason for the notification

a)

Position / status

PDMR

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	100,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Jamie Yexley

2

Reason for the notification

a)

Position / status

PDMR

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	100,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Patrick Breen

2

Reason for the notification

a)

Position / status

PDMR

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	150,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Angela Robertson

2

Reason for the notification

a)

Position / status

PDMR

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	100,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

John Bannister

2

Reason for the notification

a)

Position / status

PDMR

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	100,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Derek Brady

2

Reason for the notification

a)

Position / status

PDMR

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	150,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Jill Hepburn

2

Reason for the notification

a)

Position / status

PDMR

Initial notification / amendment

Initial notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Omega Diagnostics Group PLC                         

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s):  section to be prepared for (i) each type of instrument; (ii) each type of transaction; (iii) each date and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 4p each ("Ordinary Shares")

Identification code

ISIN:  GB00B1VCP282

b)

Nature of transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s)	Volume(s)
n/a	150,000

d)

Aggregated information

As above

e)

Date of the transaction

23 January 2020

f)

Place of the transaction

N/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHEAEFDADFEEAA